Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms
Aneurysms, Arteriovenous Malformations
About this trial
This is an interventional treatment trial for Aneurysms focused on measuring giant aneurysms, arteriovenous malformations, minocycline, doxycycline, BAVM
Eligibility Criteria
Inclusion Criteria: Giant aneurysms or brain arteriovenous malformations (BAVM) Female patients of child bearing age using effective birth control, males Creatinine no greater than 2.0 mg/dl ALT no greater than 2 times upper limit of control Exclusion Criteria: Unstable medical illness Contraindications to Tetracycline History of vestibular disease, (except benign positional vertigo) Prior tetracycline use within 2 mos of baseline visit. History of noncompliance with treatment or other protocols History of systemic lupus Patients not eligible for MRI
Sites / Locations
- University of California
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Brain AVMs
Aneurysms
This trial is to investigate the use of minocycline or doxycycline as medical therapy, can minocycline or doxycycline induce biologically significant changes in the enzyme system thought to be related to spontaneous growth/rupture of these malformations. Finally, can patients safely tolerate these medications over an extended period of time.